<!DOCTYPE html>
<meta charset="utf8"/>
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<html>
<link
  rel="stylesheet"
  href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css"
/>
<body>
    <header>
        <nav>
            <ul>
                <li><h1>QuiVoteQuoi?</h1></li>
            </ul>
            <ul>
                <li><a href="/subjects">Sujets</a></li>
            </ul>
        </nav>
    </header>
    <main>
        <section>
            <a href="/">⟵ Retourner à la recherche</a>
            <h2>Resolution on Commission Implementing Regulation (EU) 2022/1480 of 7 September 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bensulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fludioxonil, flufenacet, flumetralin, fosthiazate, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulphur, tebufenpyrad, tetraconazole, tri-allate, triflusulfuron and tritosulfuron</h2>
            <h3>Sujets</h3>
            <ul>
                
                    
                    <li><a href="/subject/3.10.09">Phytosanitaire, phytopharmacie, agriculture biologique, agro-génétique: généralités</a></li>
                
            </ul>
            <h3>Votes</h3>
            
            <ul>
                
                <li><a href="/vote/149085">Objection conformément à l’article 112, paragraphes 2 et 3, du règlement: substances actives, y compris l’hydroxy-8-quinoléine, le chlorotoluron et le difénoconazole - Objection pursuant to Rule 112 (2) and (3): Active substances, including 8-hydroxyquinoline, chlorotoluron and difenoconazole - Einwand gemäß Artikel 112 Absätze 2 und 3 GO: Wirkstoffe, darunter 8-Hydroxychinolin, Chlortoluron und Difenoconazol - B9-0460/2022 - Proposition de résolution</a></li>
                
            </ul>
        </section>
    </main>
</body>
</html>